HK1208375A1 - Improved complexes and compositions containing curcumin - Google Patents
Improved complexes and compositions containing curcuminInfo
- Publication number
- HK1208375A1 HK1208375A1 HK15109169.9A HK15109169A HK1208375A1 HK 1208375 A1 HK1208375 A1 HK 1208375A1 HK 15109169 A HK15109169 A HK 15109169A HK 1208375 A1 HK1208375 A1 HK 1208375A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions containing
- containing curcumin
- complexes
- improved
- improved complexes
- Prior art date
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title 2
- 229940109262 curcumin Drugs 0.000 title 1
- 235000012754 curcumin Nutrition 0.000 title 1
- 239000004148 curcumin Substances 0.000 title 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ60014612 | 2012-05-22 | ||
PCT/NZ2013/000086 WO2013176555A1 (en) | 2012-05-22 | 2013-05-22 | Improved complexes and compositions containing curcumin |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1208375A1 true HK1208375A1 (en) | 2016-03-04 |
Family
ID=49624145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15109169.9A HK1208375A1 (en) | 2012-05-22 | 2015-09-18 | Improved complexes and compositions containing curcumin |
Country Status (10)
Country | Link |
---|---|
US (1) | US20150104503A1 (ja) |
EP (2) | EP3666265A1 (ja) |
JP (1) | JP6211603B2 (ja) |
KR (2) | KR20150035730A (ja) |
CN (3) | CN110870857A (ja) |
AU (1) | AU2013264466B2 (ja) |
CA (1) | CA2910089A1 (ja) |
HK (1) | HK1208375A1 (ja) |
IN (1) | IN2014MN02552A (ja) |
WO (1) | WO2013176555A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013220974A1 (de) * | 2013-10-16 | 2015-04-16 | Briu Gmbh | Zusammensetzung zur oralen Administration von Curcumin |
JP6987528B2 (ja) * | 2017-05-12 | 2022-01-05 | 小林製薬株式会社 | クルクミノイド含有錠剤 |
CN109589410B (zh) * | 2018-12-26 | 2022-02-01 | 晨光生物科技集团股份有限公司 | 一种姜黄素制剂及其制备方法 |
CN109846865B (zh) * | 2018-12-26 | 2022-03-25 | 晨光生物科技集团股份有限公司 | 一种姜黄素制剂及其制备方法 |
KR102169710B1 (ko) * | 2020-01-08 | 2020-10-26 | 제주대학교 산학협력단 | 커큐민 나노스피어, 그 제조방법 및 이의 용도 |
CN115461050B (zh) * | 2020-09-11 | 2023-11-28 | 李宗谚 | 药学组合物及其于治疗肌少症的用途 |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
WO2023161955A1 (en) * | 2022-02-28 | 2023-08-31 | Gidaa Life Sciences Pvt. Ltd. | A phytoactive encapsulated formulation for neurodegenerative diseases |
CN115813780A (zh) * | 2022-03-30 | 2023-03-21 | 广东格烯生物科技股份有限公司 | 一种含四氢姜黄素的纳米级祛黄组合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
PL1871399T3 (pl) | 2005-04-18 | 2011-09-30 | Sc Dicophar | Zastosowanie lecytyny jako leku w leczeniu łuszczycy |
WO2007098118A2 (en) * | 2006-02-16 | 2007-08-30 | Byron Robinson Pharmaceutical, Inc. | Antineoplastic and curcumin derivatives and methods of preparation and use |
EP1993365B1 (en) * | 2006-03-06 | 2013-05-08 | The Regents of the University of California | Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
EP1837030A1 (en) * | 2006-03-09 | 2007-09-26 | INDENA S.p.A. | Phospholipid complexes of curcumin having improved bioavailability |
JP2009543873A (ja) * | 2006-07-19 | 2009-12-10 | ザ、ボード、アヴ、リージェンツ、アヴ、ズィ、ユーニヴァーサティ、アヴ、テクサス、システィム | 炎症性腸疾患を治療するためのリン脂質および5−アミノサリチル酸を含有する医薬品の調製 |
IT1395086B1 (it) * | 2009-03-11 | 2012-09-05 | Velleja Res Srl | Composizioni comprendenti curcumina in forma complessata con fosfolipidi e piperina ad azione chemio-sensibilizzante |
-
2013
- 2013-05-22 CN CN201911125449.XA patent/CN110870857A/zh active Pending
- 2013-05-22 CN CN201380038818.6A patent/CN104540515A/zh active Pending
- 2013-05-22 CN CN202010235467.XA patent/CN111407752A/zh active Pending
- 2013-05-22 AU AU2013264466A patent/AU2013264466B2/en active Active
- 2013-05-22 JP JP2015513962A patent/JP6211603B2/ja not_active Expired - Fee Related
- 2013-05-22 EP EP20150592.2A patent/EP3666265A1/en not_active Withdrawn
- 2013-05-22 WO PCT/NZ2013/000086 patent/WO2013176555A1/en active Application Filing
- 2013-05-22 US US14/402,071 patent/US20150104503A1/en not_active Abandoned
- 2013-05-22 CA CA2910089A patent/CA2910089A1/en not_active Abandoned
- 2013-05-22 KR KR20147036049A patent/KR20150035730A/ko active Application Filing
- 2013-05-22 KR KR1020197021718A patent/KR20190090075A/ko not_active Application Discontinuation
- 2013-05-22 EP EP13793432.9A patent/EP2852395A4/en not_active Withdrawn
-
2014
- 2014-12-16 IN IN2552MUN2014 patent/IN2014MN02552A/en unknown
-
2015
- 2015-09-18 HK HK15109169.9A patent/HK1208375A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013176555A1 (en) | 2013-11-28 |
CA2910089A1 (en) | 2013-11-28 |
KR20190090075A (ko) | 2019-07-31 |
US20150104503A1 (en) | 2015-04-16 |
CN111407752A (zh) | 2020-07-14 |
JP6211603B2 (ja) | 2017-10-11 |
CN104540515A (zh) | 2015-04-22 |
CN110870857A (zh) | 2020-03-10 |
EP2852395A4 (en) | 2015-12-16 |
AU2013264466A1 (en) | 2015-01-22 |
IN2014MN02552A (ja) | 2015-07-24 |
AU2013264466B2 (en) | 2017-09-07 |
EP3666265A1 (en) | 2020-06-17 |
JP2015518862A (ja) | 2015-07-06 |
KR20150035730A (ko) | 2015-04-07 |
EP2852395A1 (en) | 2015-04-01 |
AU2013264466A2 (en) | 2016-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252566B (en) | Pharmacy preparations and methods | |
HK1213798A1 (zh) | 治療性化合物和組合物 | |
IL235875A0 (en) | An anti-mucus preparation based on xylitol and methods and preparations related thereto | |
EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
HK1208375A1 (en) | Improved complexes and compositions containing curcumin | |
HK1207817A1 (en) | Composition comprising herbs | |
HK1216250A1 (zh) | '- '-羥基-二氫麥角胺化合物及組合物 | |
HK1205112A1 (en) | Enzyme-activating compounds and compositions | |
GB201315350D0 (en) | Methods and compositions | |
EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
GB201315347D0 (en) | Methods and compositions | |
IL237542A0 (en) | Amphiphilic compounds, their preparations and uses | |
IL237540B (en) | Amphiphilic compounds, their preparations and uses | |
IL237541B (en) | Amphiphilic compounds, their preparations and uses | |
IL237538A0 (en) | Amphiphilic compounds, their preparations and uses | |
EP2838365A4 (en) | ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | |
EP2834635A4 (en) | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
IL237539A0 (en) | Amphiphilic compounds, their preparations and uses | |
LT2830587T (lt) | Odą apsauganti ir odos pusiausvyrą palaikanti kompozicija | |
GB201215414D0 (en) | Composition and use |